A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos

Human Molecular Genetics

Volumn 9, Issue 11, 2000, Pages 1603-1613

  Iwata, Tomoko ^a   Chen, Lin ^b   Li, Cui Ling ^b   Ovchinnikov, Dmitry A ^c   Behringer, Richard R ^c   Francomano, Clair A ^a   Deng, Chu Xia ^b  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE GROWTH; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DWARFISM; EMBRYO; EMBRYO DEVELOPMENT; ENCHONDRAL OSSIFICATION; GENE EXPRESSION; GENE MUTATION; GROWTH PLATE; LETHAL MUTANT; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SKELETON MALFORMATION;

EID: 0034234569     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.11.1603     Document Type: Article

References (59)

1. Basilico, C. and Moscatelli, D. (1992) The FGF family of growth factors and oncogenes. Adv. Cancer Res., 59, 115-165.
2. Szebenyi, G. and Fallon, J.F. (1999) Fibroblast growth factors as multi-functional signaling factors. Int. Rev. Cytol., 185, 45-106.
3. Johnson, D.E. and Williams, L.T. (1993) Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res., 60, 1-41.
4. Muenke, M. and Schell, U. (1995) Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet., 11, 308-313.
5. Webster, M.K. and Donoghue, D.J. (1997) FGFR activation in skeletal disorders: too much of a good thing. Trends Genet., 13, 178-182.
6. Naski, M.C., Wang, Q., Xu, J. and Ornitz, D.M. (1996) Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nature Genet., 13, 233-237.
7. Webster, M.K., D'Avis, P.Y., Robertson, S.C. and Donoghue, D.J. (1996) Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II. Mol. Cell. Biol., 16, 4081-4087.
8. Webster, M.K. and Donoghue, D.J. (1996) Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J., 15, 520-527.
9. Naski, M.C. and Ornitz, D.M. (1998) FGF signaling in skeletal development. Front. Biosci., 3, D781-D794.
10. Wang, Y., Spatz, M.K., Kannan, K., Hayk, H., Avivi, A., Gorivodsky, M., Pines, M., Yayon, A., Lonai, P. and Givol, D. (1999) A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3. Proc. Natl Acad. Sci. USA, 96, 4455-4460.
11. Segev, O., Chumakov, I., Nevo, Z., Givol, D., Madar-Shapiro, L., Sheinin, Y., Weinreb, M. and Yayon, A. (2000) Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3 (G380R) transgenic mice. Hum. Mol. Genet., 9, 249-258.
12. Chen, L., Adar, R., Yang, X., Monsonego, E.O., Li, C., Hauschka, P.V., Yayon, A. and Deng, C.X. (1999) Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J. Clin. Invest., 104, 1517-1525.
13. Li, C., Chen, L., Iwata, T., Kitagawa, M., Fu, X.Y. and Deng, C.X. (1999) A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Hum. Mol. Genet., 8, 35-44.
14. Kanai, M., Goke, M., Tsunekawa, S. and Podolsky, D.K. (1997) Signal transduction pathway of human fibroblast growth factor receptor 3. Identification of a novel 66-kDa phosphoprotein. J. Biol. Chem., 272, 6621-6628.
15. Legeai-Mallet, L., Benoist-Lasselin, C., Delezoide, A.L., Munnich, A. and Bonaventure, J. (1998) Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia. J. Biol. Chem., 273, 13007-13014.
16. Weksler, N.B., Lunstrum, G.P., Reid, E.S. and Horton, W.A. (1999) Differential effects of fibroblast growth factor (FGF)9 and FGF2 on proliferation, differentiation and terminal differentiation of chondrocytic cells in vitro. Biochem. J., 342, 677-682.
17. Sahni, M., Ambrosetti, D.C., Mansukhani, A., Gertner, R., Levy, D. and Basilico, C. (1999) FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev., 13, 1361-1366.
18. Erlebacher, A., Filvaroff, E.H., Gitelman, S.E. and Derynck, R. (1995) Toward a molecular understanding of skeletal development. Cell, 80, 371-378.
19. Karsenty, G., Ducy, P., Starbuck, M., Priemel, M., Shen, J., Geoffroy, V. and Amling, M. (1999) Cbfal as a regulator of osteoblast differentiation and function. Bone, 25, 107-108.
20. Vortkamp, A., Lee, K., Lanske, B., Segre, G.V., Kronenberg, H.M. and Tabin, C.J. (1996) Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science, 273, 613-622.
21. Karp, S.J., Schipani, E., St-Jacques, B., Hunzelman, J., Kronenberg, H. and McMahon, A.P. (2000) Indian Hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone-related protein-dependent and -independent pathways. Development, 127, 543-548.
22. Colvin, J.S., Bohne, B.A., Harding, G.W., McEwen, D.G. and Ornitz, D.M. (1996) Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nature Genet., 12, 390-397.
23. Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A. and Leder, P. (1996) Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell, 84, 911-921.
24. Lakso, M., Pichel, J.G., Gorman, J.R., Sauer, B., Okamoto, Y., Lee, E., Alt, F.W. and Westphal, H. (1996) Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl Acad. Sci. USA, 93, 5860-5865.
25. Kaufman, M.H. and Bard, J.B.L. (1999) The Anatomical Basis of Mouse Development. Academic Press, San Diego, CA, pp. 93-108.
26. Peters, K., Ornitz, D., Werner, S. and Williams, L. (1993) Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev. Biol., 155, 423-430.
27. Chung, U.I., Lanske, B., Lee, K., Li, E. and Kronenberg, H. (1998) The parathyroid hormone/parathyroid hormone-related peptide receptor coordinates endochondral bone development by directly controlling chondrocyte differentiation. Proc: Natl Acad. Sci. USA, 95, 13030-13035.
28. Kaufman, R.L., Rimoin, D.L., McAlister, W.H. and Kissane, J.M. (1970) Thanatophoric dwarfism. Am. J. Dis. Child., 120, 53-57.
29. Weinstein, M., Xu, X., Ohyama, K. and Deng, C.X. (1998) FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development, 125, 3615-3623.
30. Powell, P.P., Wang, C.C., Horinouchi, H., Shepherd, K., Jacobson, M., Lipson, M. and Jones, R. (1998) Differential expression of fibroblast growth factor receptors 1 to 4 and ligand genes in late fetal and early postnatal rat lung. Am. J. Resp. Cell Mol. Biol., 19, 563-572.
31. Rich, C.B., Fontanilla, M.R., Nugent, M. and Foster, J.A. (1999) Basic fibroblast growth factor decreases elastin gene transcription through an AP1/cAMP-response element hybrid site in the distal promoter. J. Biol. Chem., 274, 33433-33439.
32. Ovchinnikov, D.A., Deng, J.M., Ogunrinu, G. and Behringer, R.R. (2000) Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice. Genesis, 26, 145-146.
33. Blanquaert, F., Delany, A.M. and Canalis, E. (1999) Fibroblast growth factor-2 induces hepatocyte growth factor/scatter factor expression in osteoblasts. Endocrinology, 140, 1069-1074.
34. Hurley, M.M., Lee, S.K., Raisz, L.G., Bernecker, P. and Lorenzo, J. (1998) Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures. Bone, 22, 309-316.
35. Weir, E.C., Philbrick, W.M., Amling, M., Neff, L.A., Baron, R. and Broadus, A.E. (1996) Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc. Natl Acad. Sci. USA, 93, 10240-10245.
36. Schipani, E., Lanske, B., Hunzelman, J., Luz, A., Kovacs, C.S., Lee, K., Pirro, A., Kronenberg, H.M. and Juppner, H. (1997) Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. Proc. Natl Acad. Sci. USA, 94, 13689-13694.
37. Karaplis, A.C., Luz, A., Glowacki, J., Bronson, R.T., Tybulewicz, V.L., Kronenberg, H.M. and Mulligan, R.C. (1994) Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev., 8, 277-289.
38. Lanske, B., Karaplis, A.C., Lee, K., Luz, A., Vortkamp, A., Pirro, A., Karperien, M., Defize, L.H.K., Ho, C., Mulligan, R.C. et al. (1996) PTH/ PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science, 273, 663-666.
39. St-Jacques, B., Hammerschmidt, M. and McMahon, A.P. (1999) Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev., 13, 2072-2086.
40. Ingham, P.W. (1998) Transducing Hedgehog: the story so far. EMBO J., 17, 3505-3511.
41. Johnston, R.L. and Scott, M.P. (1998) New players and puzzles in the Hedgehog signaling pathway. Curr. Opin Genet. Dev., 8, 450-456.
42. Goodrich, L.V., Milenkovic, L., Higgins, K.M. and Scott, M.P. (1997) Altered neural cell fates and medulloblastoma in mouse patched mutants. Science, 277, 1109-1113.
43. 1 events. Cancer Res., 57, 1750-1757.
44. Liu, J.F., Issad, T., Chevet, E., Ledoux, D., Courty, J., Caruelle, J.P., Barritault, D., Crepin, M. and Bertin, B. (1998) Fibroblast growth factor-2 has opposite effects on human breast cancer MCF-7 cell growth depending on the activation level of the mitogen-activated protein kinase pathway. Eur. J. Biochem., 258, 271-276.
45. Ornitz, D.M. and Leder, P. (1992) Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J. Biol. Chem., 267, 16305-16311.
46. Su, W.C., Kitagawa, M., Xue, N., Xie, B., Garofalo, S., Cho, J., Deng, C., Horton, W.A. and Fu, X.Y. (1997) Activation of Stat 1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature, 386, 288-292.
47. 1 checkpoint control. Cell, 82, 675-684.
48. Meraz, M.A., White, J.M., Sheehan, K.C., Bach, E.A., Rodig, S.J., Dighe, A.S., Kaplan, D.H., Riley, J.K., Greenlund, A.C., Campbell, D. et al (1996) Targeted disruption of the Stall gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell, 84, 431-442.
49. Durbin, J.E., Hackenmiller, R., Simon, M.C. and Levy, D.E. (1996) Targeted disruption of the mouse Stat 1 gene results in compromised innate immunity to viral disease. Cell, 84, 443-450.
50. Udy, G.B., Towers, R.P., Snell, R.G., Wilkins, R.J., Park, S.H., Ram, P.A., Waxman, D.J. and Davey, H.W. (1997) Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl Acad. Sci. USA, 94, 7239-7244.
51. Teglund, S., McKay, C., Schuetz, E., van Deursen, J.M., Stravopodis, D., Wang, D., Brown, M., Bodner, S., Grosveld, G. and Ihle, J.N. (1998) Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell, 93, 841-850.
52. Naski, M.C., Colvin, J.S., Coffin, J.D. and Ornitz, D.M. (1998) Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development, 125, 4977-4988.
53. Minowada, G., Jarvis, L.A., Chi, C.L., Neubuser, A., Sun, X., Hacohen, N., Krasnow, M.A. and Martin, G.R. (1999) Vertebrate Sprouty genes are induced by FGF signaling and can cause chondrodysplasia when overexpressed. Development, 126, 4465-4475.
54. Arikawa-Hirasawa, E., Watanabe, H., Takami, H., Hassell, J.R. and Yamada, Y. (1999) Perlecan is essential for cartilage and cephalic development. Nature Genet., 23, 354-358.
55. Cappellen, D., De Oliveira, C., Ricol, D., de Medina, S., Bourdin, J., Sastre-Garau, X., Chopin, D., Thiery, J.P. and Radvanyi, F. (1999) Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nature Genet., 23, 18-20.
56. Chesi, M., Nardini, E., Brents, L.A., Sehrock, E., Ried, T., Kuehl, W.M. and Bergsagel, P.L. (1997) Frequent translocation t(4; 14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nature Genet., 16, 260-264.
57. Yang, X., Li, C, Xu, X. and Deng, C. (1998) The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc. Natl Acad. Sci. USA, 95, 3667-3672.
58. Deng, C.X., Wynshaw-Boris, A., Shen, M.M., Daugherty, C., Ornitz, D.M. and Leder, P. (1994) Murine FGFR-I is required for early post-implantation growth and axial organization. Genes Dev., 8, 3045-3057.
59. McLeod, M.J. (1980) Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology, 22, 299-301.